↓ Skip to main content

Dove Medical Press

Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis

Overview of attention for article published in Drug Design, Development and Therapy, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter
38 X users
facebook
1 Facebook page

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
45 Mendeley
Title
Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis
Published in
Drug Design, Development and Therapy, March 2019
DOI 10.2147/dddt.s189156
Pubmed ID
Authors

Tianbiao Zhou, Shujun Lin, Shen Yang, Wenshan Lin

X Demographics

X Demographics

The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 45 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 13%
Student > Postgraduate 5 11%
Student > Master 4 9%
Student > Doctoral Student 2 4%
Student > Bachelor 2 4%
Other 8 18%
Unknown 18 40%
Readers by discipline Count As %
Medicine and Dentistry 21 47%
Biochemistry, Genetics and Molecular Biology 1 2%
Business, Management and Accounting 1 2%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Immunology and Microbiology 1 2%
Other 3 7%
Unknown 17 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2021.
All research outputs
#1,795,986
of 26,158,673 outputs
Outputs from Drug Design, Development and Therapy
#80
of 2,294 outputs
Outputs of similar age
#40,157
of 371,074 outputs
Outputs of similar age from Drug Design, Development and Therapy
#3
of 39 outputs
Altmetric has tracked 26,158,673 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,294 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 371,074 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.